Coronary Artery Bypass Surgery in the Septuagenarian

Similar documents
Coronary Artery Bypass Surgery in Patients Over Age 70 Years: Report from the Milwaukee Cardiovascular Data Registry

Coronary atherosclerotic heart disease remains the number

Assessing Cardiac Risk in Noncardiac Surgery. Murali Sivarajan, M.D. Professor University of Washington Seattle, Washington

2016 Physician Quality Reporting System Data Collection Form: Coronary Artery Bypass Graft (CABG) (for patients aged 18 years and older)

Setting The setting was a hospital. The economic study was carried out in Australia.

Review of 131 Consecutive Patients Gerald F. Geisler, M.D., Maurice Adam, M.D., Ben F. Mitchel, M.D., Cary J. Lambert, M.D., and J. Peter Thiele, M.D.

Useful? Definition of High-risk? Pre-OP/Intra-OP/Post-OP? Complication vs Benefit? Mortality? Morbidity?

Results of Reoperation

Management Strategy for Simultaneous Carotid Endarterectomy and Coronary Revascularization

CORONARY ARTERY BYPASS GRAFT (CABG) MEASURES GROUP OVERVIEW

CLINICAL COMMUNIQUE 16 YEAR RESULTS

and Coronary Artery Surgery George M. Callard, M.D., John B. Flege, Jr., M.D., and Joseph C. Todd, M.D.

Journal of the American College of Cardiology Vol. 35, No. 5, by the American College of Cardiology ISSN /00/$20.

Indications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014

Coronary artery surgery: indications and recent experience

Distribution Of Grafts In Aortocoronary Bypass Surgery: Cardiovascular Surgery Fellowship Experience.

EACTS Adult Cardiac Database

Importance of the third arterial graft in multiple arterial grafting strategies

in Patients Having Aortic Valve Replacement John T. Santinga, M.D., Marvin M. Kirsh, M.D., Jairus D. Flora, Jr., Ph.D., and James F. Brymer, M.D.

Type of intervention Treatment. Economic study type Cost-effectiveness analysis.

Cardiac disease is well known to be the leading cause

16 YEAR RESULTS Carpentier-Edwards PERIMOUNT Mitral Pericardial Bioprosthesis, Model 6900

Myocardial enzyme release after standard coronary artery bypass grafting

ESC Congress 2011 SIMULTANEOUS HYBRID REVASCULARIZATION OF CAROTID AND CORONARY DISEASE INITIAL RESULTS OF A NEW THERAPEUTIC APPROACH

Competitive Blood Flow in the- Coronary Circulation Simulating Progression of Proximal Coronary Artery Disease After Saphenous Vein Bypass Surgery*

TSDA ACGME Milestones

Bicuspid aortic root spared during ascending aorta surgery: an update of long-term results

Detailed Order Request Checklists for Cardiology

In the United States, 97 million overweight or obese

The Influence of Previous Percutaneous Coronary Intervention in Patients Undergoing Off-Pump Coronary Artery Bypass Grafting

Analysis of Mortality Within the First Six Months After Coronary Reoperation

Risk Stratification Using The Society of Thoracic Surgeons Program

University of Florida Department of Surgery. CardioThoracic Surgery VA Learning Objectives

SUPPLEMENTAL MATERIAL

Summary Protocol ISRCTN / NCT REVIVED-BCIS2 Summary protocol version 4, May 2015 Page 1 of 6

Distal Coronary Artery Dissection Following Percutaneous Transluminal Coronary Angioplasty

Reoperative Coronary Artery Bypass Grafting: Analysis of Early And Late Outcomes

Supplementary Material to Mayer et al. A comparative cohort study on personalised

ery: Comparison of Predicted and Observed Resu ts

Balloon angioplasty versus bypass grafting in the era of coronary stenting Ekstein S, Elami A, Merin G, Gotsman M S, Lotan C

Chairman and O. Wayne Isom Professor Department of Cardiothoracic Surgery Weill Cornell Medicine

Aberrant Right Subclavian Artery Aneurysm

Copyright by ICR Publishers 2005

Contemporary outcomes for surgical mitral valve repair: A benchmark for evaluating emerging mitral valve technology

Preoperative risk factors for carotid endarterectomy: Defining the patient at high risk

Counterpulsation. John N. Nanas, MD, PhD. Professor and Head, 3 rd Cardiology Dept, University of Athens, Athens, Greece

OPCAB IS NOT BETTER THAN CONVENTIONAL CABG

Intraoperative application of Cytosorb in cardiac surgery

LM stenting - Cypher

Declaration of conflict of interest NONE

Accepted Manuscript. Simulating the trajectory of off-pump surgery- the heroic defense of the homograft. Ari A. Mennander, MD PhD

Reconstruction of the intervalvular fibrous body during aortic and

The increase in the lifespan of the western population

Chapter 4: Cardiovascular Disease in Patients With CKD

Saphenous Vein Autograft Replacement

The Final 10-Year Follow-up Results from the Bari Randomized Trial J Am Coll Cardiol (2007) 49;1600-6

To provide information on the use of acetyl salicylic acid in the treatment and prevention of vascular events.

Disclosures The PREVENT IV Trial was supported by Corgentech and Bristol-Myers Squibb

The operative mortality rate after redo valvular operations

Non-Selective Carotid Artery Ultrasound Screening in Patients Undergoing Coronary Artery Bypass Grafting: Is It Necessary?

Effect of Intravascular Ultrasound- Guided vs. Angiography-Guided Everolimus-Eluting Stent Implantation: the IVUS-XPL Randomized Clinical Trial

Percutaneous Coronary Interventions Without On-site Cardiac Surgery

FFR and CABG Emanuele Barbato, MD, PhD, FESC Cardiovascular Center Aalst, Belgium

Further Evaluation. Technique of Coronary Artery Bypass. of the Circular Sequential Vein Graft

Management of Fusiform Ascending Aortic Aneurysms

Early and Late Results in Patients with Carotid Disease Undergoing Myocardial Revascularization

Surgery for patients with diffuse atherosclerotic disease

Changing profile of patients undergoing redo-coronary artery surgery q

Complete Proximal Occlusion of All Three Main Coronary Arteries Complicated With a Left Main Coronary Aneurysm: A Case Report

Quality Measures MIPS CV Specific

I internal mammary artery (IMA) is widely accepted as

Improved long-term survival has been demonstrated by

Chapter 4: Cardiovascular Disease in Patients With CKD

Coronary Atherosclerosis in Valvular Heart Disease

RCSIsmjoriginal article

Postoperative atrial fibrillation predicts long-term survival after aortic-valve surgery but not after mitral-valve surgery: a retrospective study

Coronary artery bypass grafting (CABG) is a temporary treatment for a

Cardiac surgery in Victorian public hospitals, Public report

Patient referral for elective coronary angiography: challenging the current strategy

Is a minimally invasive approach for re-operative aortic valve replacement superior to standard full resternotomy?

Operative Risk in Patients with Previous Coronary Artery Bypass

THE NATIONAL QUALITY FORUM

Managing Hypertension in the Perioperative Arena

Aortic valve implantation using the femoral and apical access: a single center experience.

Declaration of conflict of interest. Nothing to disclose

Aortic Valve Practice Guidelines: What Has Changed and What You Need to Know

Results of Transapical Valves. A.P. Kappetein Dept Cardio-thoracic surgery

ORIGINAL PAPER. The long-term results and changing patterns of biological valves at the mitral position in contemporary practice in Japan

LOW DOSE ASPIRIN CARDIOVASCULAR DISEASE FOR PROPHYLAXIS OF FOR BACKGROUND USE ONLY NOT TO BE USED IN DETAILING

FFR vs. icecg in Coronary Bifurcations (FIESTA) - preliminary results. Dobrin Vassilev MD, PhD National Heart Hospital Sofia, Bulgaria

Serum triglycerides and HDL cholesterol major predictors of long-term survival after coronary surgery

Australia and New Zealand Source Registry Edwards Sapien Aortic Valve 30 day Outcomes

Key Words Aneurysms Aortic disease Atherosclerosis Heart surgery Elderly

Ventricular Function and the Native Coronary Circulation Five Years after Myocardial Revascularhation

Paris, August 28 th Gian Paolo Ussia on behalf of the CoreValve Italian Registry Investigators

The Journal of Thoracic and Cardiovascular Surgery

IN ELECTIVE CORONARY ARTERY BYPASS GRAFTING, PREOPERATIVE TROPONIN T LEVEL PREDICTS THE RISK OF MYOCARDIAL INFARCTION

Surgical Therapy for Prinzmetal's Variant Angina

Influence of Planned Six-Month Follow-Up Angiography on Late Outcome After Percutaneous Coronary Intervention A Randomized Study

Transcription:

Coronary Artery Bypass Surgery in the Septuagenarian Jerry B. Gooch, M.D., H. Edward Garrett, M.D., J.T. Davis, Jr., M.D., and Robert L. Richardson, M.D. Analyzed during a 3 -year period wvere 86 patientsfrom 70 to 80 years of age who underwent coronary artery bypass grafting without other cardiac procedures. The series included 57 men (66%) and 29 women (34%). The average follow-up period was 27 months. The early mortality rate for the men was 5.2%, and the overall mortality was 8.7%. This compared with an age-adjusted nationally expected death rate of 12.17% for this age group during this period of time. The early mortality ratefor the women was 6.9%, with ani overall mortality rate of 13.9%. This compared with an 8.7% age-adjusted nationally expected death rate. Factors which did not affect mortality in this particular series included smoking, hypertension, diabetes, and ejection fraction. Factors which did affect mortality included peripheral vascular disease (29% mortality), and postoperative complications (38% mortality). Of the 86 patients operated on from 1978 through 1980, ages 70 to 80, 88% are alive (76 of 86 patients). Of the patients living, 60.5% have no chest pain, and 26.3% describe their chest pain as significantly improved. When medical treatment alone fails, coronary artery bypass grafting is possible in the older age group to relieve disablinig angina and improve the quality of life, with very acceptable mortality rates. T HE EXACT role of coronary artery bypass grafting in the elderly has been questionable.'2 The suspected increase in mortality rates and the possibility of less than optimum results in this age group3 have led to some reluctance in the recommendation of surgery. Our impression has been that this is a viable therapeutic option to pursue regardless of age. This study, along with others,4 points out the fact that both mortality rates and quality of life can be improved in this age group, although the problems may be greater. Patient Selection Technical changes that took place in 1976 and 1977 caused us to pick the beginning date of January 1, 1978 for this rev%iew. All Caucasian patients between the ages of 70 and 80 were reviewed. To have a minimal follow-up of at least 18 months, From the Surgical Group for Thoracic and Cardiovascular Diseases, Mlemphis, Tennessee. Presented at the Ninth Annual Scientific Symposium of the Denton A. Cooley Cardiovascular Surgical Society, Sept. 20-23, 1982, Athens, Greece. Address for repnrnts: Surgical Group for Thoracic and Cardiovascular Diseases, P.C., 1325 Eastmoreland Avenue, Suite 340, Memphis, Tennessee 38104. Texas Heart Institute Journal 137

the study was stopped December 31, 1980. There were 57 males and 29 females in this group. Follow-up was 100%. Life Expectancy A review of the data (Table I) indicates that bypass grafting in the male, aged 70 to 80, may actually increase the life expectancy slightly, although the numbers are not large enough to be statistically significant. With an average follow-up of 24 months, the percentage of those who died was 8.8%, contrasted with an expected rate of 11%. The majority (5.3%) of the postoperative deaths occurred early and were related to the operative procedure. This seems to indicate improvement in longterm survival rates that could continue to increase with time. Women in their seventh decade did not fare as well as their male counterparts. Although fewer in number, the mortality rates for women were quite different. The expected mortality rate of 7.3% was considerably lower than the observed rate of 14%. The perioperative death rate was satisfactory (6.9%), but increased significantly with time. This factor was especially apparent in the more elderly women. Predictive Factors Certain preexisting conditions and operative occurrences served to predictably influence end results. Patients in this age group who had had previous vascular surgery were more at risk than their first-time counterparts. Although the number was small, it supported our impression that patients with proven, preexisting arteriosclerotic disease did not generally fare as well. This includes those patients who had undergone surgery for aneurysm, carotid stenosis, or peripheral vascular lesions (Table II). Patients with any perioperative problem had increased mortality (Table III). Reexploration of the mediastinum for bleeding carried with it a 66% death rate. The development of complete heart block, necessitating the implantation of a permanent pacemaker, was also significant. Other factors, such as intraaortic balloon removal and sternal dehiscence, were rather infrequent. Interestingly, all five patients who had had an intraaortic balloon inserted at the time of surgery did very well. The number of bypasses per patient showed an increase in risk in both the lower and upper ranges. Those patients having three or four distal anastomoses exhibited only a 3.9% mortality rate. Patients having more grafts were much more at risk (Table IV). The immediate postoperative status was an important factor. Of the 69 patients who were asymptomatic (other than incisional pain), only one experienced an early death, and to date there have been only three additional deaths. Average follow-up of this group is 25.8 months. Symptomatic patients have exhibited a 35% mortality rate over an average follow-up time of 14.5 months (Table V). The presence of hypertension, diabetes and pulmonary disease did not influence the outcome. We did not attempt to analyze the preexisting cardiac status, as these factors are well known to all and were taken into consideration when making the surgical decision. The development of Dressler's syndrome increased the length of hospital stay, but did not influence the outcome. Follow-Up Seventy-seven of the 86 patients were alive at the time of follow-up contact: Forty-seven are asymptomatic and are able to carry on their usual life styles. Thirty are symptomatic with angina pectoris. Half of these patients have had to restrict their activity level, even though 66% stated that their pain pattern is improved compared to the preoperative status (Table VI). Discussion Age must influence the decision for coronary artery bypass grafting. The effect of variables present in the older age groups has been studied by several observers.46 138 Vol. 10, No. 2, June 1983

TABLE 1. Mortality Results Following Coronary Artery Bypass Grafts in the 70-80 Age Group Months Sex Number Follow-up Early Total Expected Male 57 24.2 5.3 8.8 11.0 Female 29 26.9 6.9 13.9 7.3 TABLE II. Relation of Proven Arteriosclerotic Disease to Death Rate Number Early Late Proven present 14 14.3 28.6 Not present 72 4.2 7.0 TABLE Ill. Relation of Associated Operations to Death Rate Operation Number Early Total None 75 2.7 4.0 Pacemaker 4 25 50 Reexploration 3 66 66 Previous CABG 2 0 0 Others 2 0 50 CABG = Coronary artery bypass graft. TABLE IV. Relation of Number of Bypasses and Mortality Rates Number Number Total of Grafts of Patients Deaths 1-2 11 2 18.2 3-4 51 2 3.9 5-7 24 5 20.8 TABLE V. Relation of Postoperative Angina to Death Rate Status Number Early Deaths Total Deaths Asymptomatic 69 1 ( 1.4%) 3 ( 4.3%) Symptomatic 17 4 (23.5%) 6 (35.3%) TABLE VI. Status of the 77 Patients at Follow- Up Asymptomatic 47 Symptomatic 30 Improved 20 (66%) Same 5 (16%) Worse 5 (16%) Texas Heart Institute Journal 139

Certain points have become evident, indicating that the efficiency of the procedure, when properly performed, does not diminish in the geriatric group. In this evaluation, we did not attempt an in-depth study of the cardiac variables that are known to influence outcome.7'8 It is our practice to limit our surgery recommendations to those people with relatively low-risk situations in this age group. The viable, active septuagenarian who does not exhibit other conditions that contraindicate surgery does not benefit from operation with an acceptable risk. The technical improvements that took place in the mid-70s have advanced cardiac surgery into a new era. Improved methods of myocardial preservation were a major factor in our selecting 1978 as the starting date for this study. Since that time, our early mortality rate has been acceptable, and the follow-up data seem to indicate good long-term results. Life expectancy may actually be improved in this select group.9 This study substantiated the long-held theory that "older patients do well as long as nothing goes wrong." Any secondary operative procedure, such as reexploration for bleeding or permanent pacemaker implantation, was indicative of problems that significantly influenced outcome. There was a correlation betwveen increased problems and the preexistence of arteriosclerotic disease. The presence of pulmonary disease, hypertension or diabetes did not seem to affect outcome. Although it is entirely subjective, each postoperative patient's own evaluation of his status proved to be very accurate. An improved long-term survival rate has been observed in those patients who noted that their angina was better immediately following operation. Summary A series of 86 patients, aged 70-80 years, who had undergone coronary artery bypass grafting without other procedures, was analyzed over a 2-year period. There were 57 men and 29 women in the study. Review of the data indicates that bypass grafting in the male in this age group may actually increase the life expectancy slightly, although the numbers are not large enough to be statistically significant. Women in the group, however, did not fare as well as their male counterparts. Seventy-seven of the 86 patients were alive at the time of follow-up contact, 47 of whom wvere asymptomatic and able to carry on their usual life style. Thirty patients had angina pectoris. The number of bypasses per patient showed an increase in risk in both the lowver- and upper-age ranges. From our analysis, certain points have become evident, indicating that the efficiency of coronary artery bypass surgery when properly performed does not diminish in the geriatric age group. References 1. Ashor GWV, Meyer BWN%, Lindesmith GG, Stiles QR, Walker GH, Tucker BL. Coronary artery disease. Surgery in 100 patients 65 years of age and older. Arch Surg 1973: 107: 30-33. 2. Hoffmann RG, Blumnleini SL, Andersoni AJ, Barboriak Jj, Walker ja, Rimm AA. The probability of surviving coronary bypass surgery. Fi e-year resuilts from 1,718 patients. JANIA 1980; 243 (13): 1341-1344. 3. Kirklin JWV, Kouchoukos NT, Blackstone EH, Oberman A. Researclh related to surgical treatmlent of coronarv arterv disease. Circulation 1979: 60 (7): 1613-1618. 4. Knapp WS, Dotiglas JS jr, Craver JM, Jones EL, King SB, Bone DK, Bradf'ord JM, Hatcher CRJr. Efficacy of coronary artery bypass graf'ting in elderly patients with coronary artery disease. Am J Cardiol 1981; 47: 923-930( 5. Meyer J, W'ukasch DC, Seybold-Epting WN', Chiariello L, Reul (j, Sandiford FM, Hallman GL, C(oolev DA. Coronary artery bypass in patients over 70 years of age: Indication and results. J Cardiol 1975; 36: 324-345. 6. Stephenson LWN', MacVaugh H III, Eddmunds LH. Surgery using cardiopulmonary bypass in the elderly. Circulation 1978; 58 (2): 250-254. 7. Russell ROJr (with 46 investigators). Unstable angina pectoris: National cooperative study group to compare surgical and medical therapy. II. In-hospital experience and initial follow-up resilts in patients with one, two and three vessel disease. Am (Cardiol 1978: 42: 839-848. 140 Vol. 10, No. 2, June 1983

8. Takaro T, Hultgren HN, Lipton MJ, Detre KM (participants in the study group). The VA cooperative randomized study of surgery for coronary arterial occlusive disease. II. Subgroup with significant left main lesions. Circulation 1976; 54 (Suppl III) (6): 107-117. 9. Isom OW, Spencer FC, Glassman E, Cunningham JN, Teiko P, Reed GE, Boyd AD. Does coronary bypass increase longevity? J Thorac Cardiovasc Surg 1978; 75 (1): 28-37. Texas Heart Institute Journal 141